Sirolimus as a second-line treatment for Graves ’ orbitopathy

ConclusionsSirolimus seems to be an effective second-line treatment for GO. Further randomized clinical trials are needed to confirm our observations.
Source: Journal of Endocrinological Investigation - Category: Endocrinology Source Type: research